With the emergence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
variants that may increase transmissibility and/or cause escape from immune responses, …

With the emergence of SARS-CoV-2 variants that may increase transmissibility and/or cause
escape from immune responses 1–3, there is an urgent need for the targeted surveillance …

The SARS-CoV-2 entry into host cells is mainly mediated by the interactions between the
viral spike protein (S) and the ACE-2 cell receptor, which are highly glycosylated. Therefore, …

Zika virus is the etiologic agent of Zika fever, and has been previously associated with cases
of microcephaly, drawing the attention of the health authorities worldwide. However, no …

Since the beginning of the SARS-CoV-2 spread in Brazil, few studies have been published
analysing the variability of viral genome. Herein, we described the dynamic of SARS-CoV-2 …

Background Reducing the transmission of SARS-CoV-2 from asymptomatic and pre-symptomatic
patients is critical in controlling the circulation of the virus. Methods This study …

The Mayaro virus (MAYV) is an arbovirus with emerging potential, though with a limited
understanding of its epidemiology and evolution due to the lack of studies and surveillance. Here…

Hepatitis C virus (HCV) is responsible for more than 180 million infections worldwide, and
about 80 % of infections are reported in Low and Middle-income countries (LMICs). Therapy is …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in Wuhan,
China, is the causative agent of the coronavirus disease 2019 (COVID-19). Since its first …

Mayaro virus (MAYV) is the etiologic agent of Mayaro Fever, a disease characterized by
dengue-like symptoms and arthralgias that can progress to a chronic condition. MAYV is …